Exact Mass: 285.0129486
Exact Mass Matches: 285.0129486
Found 234 metabolites which its exact mass value is equals to given mass value 285.0129486,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Chloraminophenamide
D000890 - Anti-Infective Agents > D013424 - Sulfanilamides CONFIDENCE standard compound; EAWAG_UCHEM_ID 3257
Ronilan
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D000726 - Androgen Antagonists CONFIDENCE standard compound; EAWAG_UCHEM_ID 3119 D016573 - Agrochemicals D010575 - Pesticides
5-Amino-4-chloro-2-(5-hydroxymuconoyl)-3(2H)-pyridazinone
Cladribine
C10H12ClN5O3 (285.06286320000004)
Cladribine is only found in individuals that have used or taken this drug. It is an antineoplastic agent used in the treatment of lymphoproliferative diseases including hairy-cell leukemia. [PubChem]Cladribine is structurally related to fludarabine and pentostatin but has a different mechanism of action. Although the exact mechanism of action has not been fully determined, evidence shows that cladribine is phosphorylated by deoxycytidine kinase to the nucleotidecladribine triphosphate (CdATP; 2-chloro-2′-deoxyadenosine 5′-triphosphate), which accumulates and is incorporated into DNA in cells such as lymphocytes that contain high levels of deoxycytidine kinase and low levels of deoxynucleotidase, resulting in DNA strand breakage and inhibition of DNA synthesis and repair. High levels of CdATP also appear to inhibit ribonucleotide reductase, which leads to an imbalance in triphosphorylated deoxynucleotide (dNTP) pools and subsequent DNA strand breaks, inhibition of DNA synthesis and repair, nicotinamide adenine dinucleotide (NAD) and ATP depletion, and cell death. Unlike other antimetabolite drugs, cladribine has cytotoxic effects on resting as well as proliferating lymphocytes. However, it does cause cells to accumulate at the G1/S phase junction, suggesting that cytotoxicity is associated with events critical to cell entry into S phase. It also binds purine nucleoside phosphorylase (PNP), however no relationship between this binding and a mechanism of action has been established. L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants > L04AA - Selective immunosuppressants L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01B - Antimetabolites > L01BB - Purine analogues C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents C471 - Enzyme Inhibitor > C2157 - Adenosine Deaminase Inhibitor C274 - Antineoplastic Agent > C798 - Radiosensitizing Agent D000970 - Antineoplastic Agents Cladribine (2-Chloro-2′-deoxyadenosine), a purine nucleoside analog, is an orally active adenosine deaminase inhibitor. Cladribine functions as an inhibitor of DNA synthesis to block the repair of the damaged DNA. Cladribine can inhibit DNA methylation. Cladribine has anti-lymphoma activity. Cladribine can be used for the research of several hematologic malignancies and multiple sclerosis[1][2].
xanthurenic acid 8-O-sulfate
Xanthurenic acid 8-O-sulfate belongs to the family of Hydroxyquinolines. These are compounds containing a quinoline moiety bearing an hydroxyl group.
2-Chloro-3'-deoxyadenosine
C10H12ClN5O3 (285.06286320000004)
5-(4-Fluorophenyl)-3-(3-nitrophenyl)-1,2,4-oxadiazole
9-Chloro-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imine
Nifuratel
C10H11N3O5S (285.04193960000003)
2-Chloro-9-(2-deoxy-beta-D-arabinofuranosyl)adenine
C10H12ClN5O3 (285.06286320000004)
ethyl 5,7-dichloro-4-hydroxyquinoline-3-carboxylate
1-(3,4-dichlorophenyl)-6,6-dimethyl-1,3,5-triazine-2,4-diamine
3,3-dimethyl-4-oxo-5-[(S)-3,3,3-trichloro-2-methylpropyl]-2-pyrrolidinone
C10H14Cl3NO2 (285.00900740000003)
Cladribine
C10H12ClN5O3 (285.06286320000004)
L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants > L04AA - Selective immunosuppressants L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01B - Antimetabolites > L01BB - Purine analogues C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents C471 - Enzyme Inhibitor > C2157 - Adenosine Deaminase Inhibitor C274 - Antineoplastic Agent > C798 - Radiosensitizing Agent D000970 - Antineoplastic Agents CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2617; ORIGINAL_PRECURSOR_SCAN_NO 2616 CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2634; ORIGINAL_PRECURSOR_SCAN_NO 2632 CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2626; ORIGINAL_PRECURSOR_SCAN_NO 2625 CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2623; ORIGINAL_PRECURSOR_SCAN_NO 2621 CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2643; ORIGINAL_PRECURSOR_SCAN_NO 2642 CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2641; ORIGINAL_PRECURSOR_SCAN_NO 2639 CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5653; ORIGINAL_PRECURSOR_SCAN_NO 5650 CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5671; ORIGINAL_PRECURSOR_SCAN_NO 5668 CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5700; ORIGINAL_PRECURSOR_SCAN_NO 5699 CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5680; ORIGINAL_PRECURSOR_SCAN_NO 5677 CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5706; ORIGINAL_PRECURSOR_SCAN_NO 5702 CONFIDENCE standard compound; INTERNAL_ID 1343; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5693; ORIGINAL_PRECURSOR_SCAN_NO 5691 Cladribine (2-Chloro-2′-deoxyadenosine), a purine nucleoside analog, is an orally active adenosine deaminase inhibitor. Cladribine functions as an inhibitor of DNA synthesis to block the repair of the damaged DNA. Cladribine can inhibit DNA methylation. Cladribine has anti-lymphoma activity. Cladribine can be used for the research of several hematologic malignancies and multiple sclerosis[1][2].
1-(5-BROMOPYRIMIDINE-2-YL)PIPERDINE-3-CARBOXYLIC ACID
N-(4-Bromo-2-methylphenyl)-3-methoxy-N-methylpropanamide
2-(5-FLUORO-1,3-DIOXO-1,3-DIHYDROISOINDOL-2-YL)BENZOICACID
3-(3,4-dichlorophenyl)-4-prop-2-enyl-1H-1,2,4-triazole-5-thione
C11H9Cl2N3S (284.98942139999997)
3-(2,6-DICHLOROPHENYL)-5-ETHYLISOXAZOLE-4-CARBOXYLIC ACID
METHYL 6-BROMO-3-OXO-3,4-DIHYDRO-2H-1,4-BENZOXAZINE-8-CARBOXYLATE
ETHYL 3-BROMO-7-OXO-4,5,6,7-TETRAHYDRO-1H-INDOLE-2-CARBOXYLATE
2-AMINO-6-CHLORO-9-(BETA-D-2-DEOXYRIBOFURANOSYL)PURINE
C10H12ClN5O3 (285.06286320000004)
1-(5-Bromopyrimidin-2-yl)piperidine-4-carboxylic acid
(E)-Methyl-2-(2-bromomethylphenyl)-2-Methoxyiminoacetate
6-(2-Bromo-ethyl)-1,3-dimethyl-1,6-dihydro-pyrrolo[3,4-d]pyrimidine-2,4-dione
7,10-Dihydro-8-nitro-7-oxo-1,10-phenanthroline-3-carboxylic acid
Ethyl 4-oxo-7-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxylate
Methyl 8-methyl-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-2-carboxylate
1-pyridin-3-ylmethyl-pyrrolidin-3-ylamine trihydrochloride
5-(2-Fluorophenyl)-3-(3-nitrophenyl)-1,2,4-oxadiazole
1-[(4-chlorophenyl)methyl]-5-methylindole-2,3-dione
POTASSIUM [2-(BENZYLOXYCARBONYLAMINO)ETHYL] TRIFLUOROBORATE
6-Bromo-4-ethyl-4-methyl-1H-benzo[d][1,3]oxazine-2(4H)-thione
C11H12BrNOS (284.98229219999996)
methyl 3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazole-4-carboxylate
(3-Bromo-4-Methyl-phenyl)-carbamic acid tert-butyl ester
6-bromo-1,4,4-trimethyl-1h-benzo[d][1,3]oxazine-2(4h)-thione
C11H12BrNOS (284.98229219999996)
Ethyl 4-hydroxy-8-(trifluoromethyl)quinoline-3-carboxylate
5,8-DICHLORO-4-HYDROXY-QUINOLINE-3-CARBOXYLIC ACID ETHYL ESTER
Ethyl 5-fluoro-7-(methylsulphonyl)-1H-indole-2-carboxylate
5,7-DICHLORO-4-HYDROXY-QUINOLINE-2-CARBOXYLIC ACID ETHYL ESTER
Nifuratel
C10H11N3O5S (285.04193960000003)
G - Genito urinary system and sex hormones > G01 - Gynecological antiinfectives and antiseptics > G01A - Antiinfectives and antiseptics, excl. combinations with corticosteroids D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D000890 - Anti-Infective Agents > D000935 - Antifungal Agents D000890 - Anti-Infective Agents > D023303 - Oxazolidinones C254 - Anti-Infective Agent > C514 - Antifungal Agent
3-(2,6-Dichlorophenyl)-N-hydroxy-5-methylisoxazole-4-carboximidamide
dimethyl 2-[(2-chloroacetyl)amino]benzene-1,4-dicarboxylate
2-(4-Bromo-3,5-dimethyl-1H-pyrazol-1-yl)-6-chloropyridine
3-Quinolinecarboxylicacid, 4-hydroxy-7-(trifluoromethyl)-, ethyl ester
Ethyl 4-hydroxy-2-(trifluoromethyl)quinoline-3-carboxylate
Ethyl 5-(aminomethyl)-1,3,4-oxadiazole-2-carboxylate
C8H10F3N3O5 (285.05725259999997)
1-(4-METHYL-2-(4-(TRIFLUOROMETHYL)PHENYL)THIAZOL-5-YL)ETHANONE
1-(3-bromopropyl)piperidine,hydrobromide
C8H17Br2N (284.97276420000003)
CARBAMIC ACID, N-(2-BROMO-4-METHYLPHENYL)-, 1,1-DIMETHYLETHYL ESTER
3-(2,6-DICHLOROPHENYL)-5-METHYLISOXAZOLE-4-CARBOHYDRAZIDE
ETHYL 5-(2,4-DICHLOROPHENYL)ISOXAZOLE-3-CARBOXYLATE
METHYL 3-METHYL-5-[4-(TRIFLUOROMETHYL)PHENYL]ISOXAZOLE-4-CARBOXYLATE
(2-CHLORO-4-MORPHOLINOTHIENO[3,2-D]PYRIMIDIN-6-YL)METHANOL
1-[2-Hydroxy-2(2-thienyl)ethyl]pyridinium bromide
C11H12BrNOS (284.98229219999996)
METHYL 4-(METHYLSULFONYL)-3-(1H-PYRROL-1-YL)THIOPHENE-2-CARBOXYLATE
ethyl 4,6-dichloro-3-formyl-1h-indole-2-carboxylate
ETHYL 5-(4-(TRIFLUOROMETHYL)PHENYL)ISOXAZOLE-3-CARBOXYLATE
Ethyl 4-hydroxy-6-(trifluoromethyl)quinoline-3-carboxylate
3-Quinolinecarboxylicacid, 6,8-dichloro-4-hydroxy-, ethyl ester
6-Azido-6-deoxy-D-galactopyranose 1-(dihydrogen phosphate)
(R)-2-(2-Chloro-5-(trifluoromethyl)phenyl)pyrrolidine hydrochloride
C11H12Cl2F3N (285.02988480000005)
2-Methyl-2-propenoic acid 2,5-dioxo-3-sulfo-1-pyrrolidinyl ester sodium salt (1:1)
3-(5-BROMO-2-METHOXY-PYRIDIN-3-YL)-ACRYLIC ACID ETHYL ESTER
2-Azido-1,3-dimethylimidazolinium hexafluorophosphate
C5H10F6N5P (285.05779820000004)
5-(3-TRIFLUOROMETHYLPHENYL)-ISOXAZOLE-3-CARBOXYLIC ACID ETHYL ESTER
Adenosine,8-chloro-2-deoxy- (9CI)
C10H12ClN5O3 (285.06286320000004)
N-(2-Aminoethyl)-5-chloroisoquinoline-8-sulfonamide
CKI-7 free base is a potent and ATP-competitive casein kinase 1 (CK1) inhibitor with an IC50 of 6 μM and a Ki of 8.5 μM. CKI-7 free base is a selective Cdc7 kinase inhibitor. CKI-7 free base also inhibits SGK, ribosomal S6 kinase-1 (S6K1) and mitogen- and stress-activated protein kinase-1 (MSK1). CKI-7 free base has a much weaker effect on casein kinase II and other protein kinases[1][2][3][4].
9-Chloro-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imine
CGS 15943 is an orally bioavailable non-xanthine Adenosine Receptor antagonist. Its Ki for human A1, A2A, A2B, and A3 Adenosine Receptors are 3.5, 4.2, 16, and 50 nM in transfected CHO cells, respectively. [1][2].
5-(6-Amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol
C10H12ClN5O3 (285.06286320000004)
5-methyl-N-[4-(2-pyridinyl)-2-thiazolyl]-2-furancarboxamide
3-Nitro-4-(2-oxo-pyrrolidin-1-yl)-benzenesulfonamide
C10H11N3O5S (285.04193960000003)
7-Phospho-2-dehydro-3-deoxy-D-arabino-heptonate
C7H10O10P-3 (285.00115900000003)
Cyanidin(1-)
An organic anion obtained by selective deprotonation of the 3- and 5-hydroxy groups of cyanidin(1+).
(1S,2R)-1-(1H-indol-3-yl)-3-(phosphonatooxy)propane-1,2-diol
2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-4H-chromen-7-olate luteolin-7-olate(1-)
2-Amino-4,5-dihydroxy-6-oxo-7-(phosphooxy)heptanoate
gentisate 5-O-beta-D-xylopyranoside
D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates
5-amino-4-chloro-2-(2-hydroxymuconoyl)pyridazin-3(2H)-one
3-deoxy-D-arabino-heptulopyranuronate 7-phosphate
C7H10O10P-3 (285.00115900000003)
3,5,6,7-Tetrahydroxy-2-(4-hydroxyphenyl)chromenium
(2S,4R,5R,6R)-6-(4-amino-2-oxopyrimidin-1-yl)-4,5-dihydroxy-3-oxooxane-2-carboxylic acid
N(1)-(5-phospho-D-ribosyl)glycinamide(1-)
Conjugate base of N(1)-(5-phospho-D-ribosyl)glycinamide. COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Scutellarein(1-)
A flavonoid oxoanion that is the conjugate base of scutellarein, obtained by selective deprotonation of the 7-hydroxy group. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).
N-(3-bicyclo[2.2.1]heptanyl)-4-chlorobenzenesulfonamide
N-[(3-phenyl-1,2,4-oxadiazol-5-yl)methyl]-2-thiophenecarboxamide
3-(3-Pyridinylmethylthio)-6-thiophen-2-ylpyridazine
6-chloro-4-hydroxy-3-(phenylmethyl)-1H-quinolin-2-one
(3R)-5-(6-amino-2-chloro-9-purinyl)-2-(hydroxymethyl)-3-oxolanol
C10H12ClN5O3 (285.06286320000004)
Aureusidin-6-olate
An organic anion that is the conjugate base of aureusidin, arising from selective deprotonation of the hydroxy group at position 6 of the benzofuran moiety; major species at pH 7.3.
(2xi)-3-deoxy-7-O-phosphonato-beta-D-threo-hept-6-ulopyranosonate
C7H10O10P-3 (285.00115900000003)
(2E)-2-(5-fluoro-2-oxo-1H-indol-3-ylidene)-2-(4-methyl-1,3-thiazol-2-yl)acetonitrile
C14H8FN3OS (285.03720899999996)
4-Amino-6-chloro-1,3-benzenedisulfonamide
D000890 - Anti-Infective Agents > D013424 - Sulfanilamides
(1S,2R)-1-C-(indol-3-yl)glycerol 3-phosphate(2-)
Dianion of (1S,2R)-1-C-(indol-3-yl)glycerol 3-phosphate arising from deprotonation of both phosphate OH groups.
[5-(ammoniomethyl)-3-furyl]methyl diphosphate(2-)
An organophosphate oxoanion obtained by deprotonation of the diphosphate OH groups and protonation of the amino group of [5-(aminomethyl)-3-furyl]methyl diphosphate; major species at pH 7.3.
Vinclozoline
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D000726 - Androgen Antagonists D016573 - Agrochemicals D010575 - Pesticides
2-hydroxygenistein(1-)
A flavonoid oxoanion obtained by deprotonation of the 7-hydroxy group of 2-hydroxygenistein. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).
1-C-(indol-3-yl)glycerol 3-phosphate(2-)
An organophosphate oxoanion resulting the from removal of two protons from the phosphate group of 1-C-(indol-3-yl)glycerol 3-phosphate.
luteolin-7-olate
A flavonoid oxoanion that is the conjugate base of luteolin, arising from selective deprotonation of the 7-hydroxy group.
catechol beta-D-glucuronide(1-)
A carbohydrate acid derivative anion resulting from the removal of a proton from the carboxy group of catechol beta-D-glucuronide.
7-Phospho-2-dehydro-3-deoxy-D-arabino-heptonate
C7H10O10P (285.00115900000003)
An organophosphate oxoanion arising from deprotonation of the carboxy and phosphate OH groups of 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonic acid; major species at pH 7.3.
(2r)-2,3-bis(formyloxy)propoxy(2-(methylamino)ethoxy)phosphinic acid
(2r)-5-hydroxy-4,4-dimethyl-2-[(2s)-3,3,3-trichloro-2-methylpropyl]-2h-pyrrol-3-one
C10H14Cl3NO2 (285.00900740000003)